The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines

Oncology Letters

Volumn 4, Issue 3, 2012, Pages 505-508

  Yan, Chong ^a   Liu, Chibo ^a   Jin, Qiaozhi ^a   Li, Zhihai ^a   Tao, Baohong ^a   Cai, Zhiyi ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Methylation; Nasopharyngeal carcinoma; Promoter; Syk gene

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PROTEIN KINASE SYK;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84863862976     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.763     Document Type: Article

References (12)

1. Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9: 1-24, 2007.
2. Li LL, Shu XS, Wang ZH, Cao Y and Tao Q: Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chin J Cancer 30: 231-239, 2011.
3. Lo KW and Huang DP: Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12: 451-462, 2002.
4. Niller HH, Wolf H and Minarovits J: Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 19: 158-164, 2009.
5. Buchholz TA and Wazer DE: Molecular biology and genetics of breast cancer development: a clinical perspective. Semin Radiat Oncol 12: 285-295, 2002.
6. Taniguchi T, Kobayashi T, Kondo J, et al: Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 266: 15790-15796, 1991.
7. Medves S and Demoulin JB: Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies. J Cell Mol Med 16: 237-248, 2012.
8. Stewart ZA and Pietenpol JA: Syk: a new player in the field of breast cancer. Breast Cancer Res 3: 5-7, 2001.
9. Efremov DG and Laurenti L: The Syk kinase as a therapeutic target in leukemia and lymphoma. Expert Opin Investig Drugs 20: 623-636, 2011.
10. Page TH, Smolinska M, Gillespie J, Urbaniak AM and FoxwellBM: Tyrosine kinases and inflammatory signalling. Curr Mol Med 9: 69-85, 2009.
11. Simons MJ: Nasopharyngeal carcinoma as a paradigm of cancer genetics. Chin J Cancer 30: 79-84, 2011.
12. Hutajulu SH, Indrasari SR, Indrawati LP, et al: Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 10: 48, 2011.